Avascular Osteonecrosis and Accompanying Anemia, Leucocytosis, and Decreased Bone Mineral Density in Renal Transplant Recipients

被引:8
|
作者
Paydas, S. [1 ]
Balal, M. [1 ]
Demir, E. [2 ]
Sertdemir, Y. [3 ]
Erken, U. [2 ]
机构
[1] Cukurova Univ, Dept Nephrol, Fac Med, TR-01330 Adana, Turkey
[2] Cukurova Univ, Dept Urol, Fac Med, TR-01330 Adana, Turkey
[3] Cukurova Univ, Dept Biostat, Fac Med, TR-01330 Adana, Turkey
关键词
FEMORAL-HEAD; ALLOGRAFT RECIPIENTS; NECROSIS; HIP;
D O I
10.1016/j.transproceed.2011.02.072
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Avascular osteonecrosis (AVN) is a complication of renal transplantation. In this study, we present 12 cases of AVN associated with renal transplantation. Methods. Renal transplant recipients (RTRs) with AVN (group I [GI]) were evaluated by using magnetic resonance imaging and blood urea nitrogen, creatinine, glucose, calcium, phosphorus, magnesium, alkaline phosphatase, parathyroid hormone, and urine analysis. We evaluated bone mineral density (BMD) of the femoral neck and lumbar vertebrae. All patients were treated with steroids, cyclosporine, or tacrolimus plus mycophenolate mofetil. Twenty-six RTRs (GII) without AVN were randomly selected as control subjects. Results. The mean ages of GI and GII, were 33.81 +/- 6.72 and 34.00 +/- 7.65 years respectively (P > .05). The mean interval between transplantation and development of AVN was 12.08 +/- 6.48 months. Although levels of blood urea nitrogen, creatinine, calcium, magnesium, and parathyroidhormone, as well as glucocorticoid doses in the first 12 months were similar in GI and GII, there were significant differences in serum alkaline phosphatase, hemoglobin levels, and white blood cell count between GI and GII (P < .05 for each). BMD T score <-1.5 was observed in 8/9 GI and 15/26 patients in GII. All of the patients with AVN except 1, were followed with conservative measures including calcium, magnesium, and vitamin D replacement therapies, bisphosphonate, and reduced or ceased glucocorticoid treatment. Although T scores of the femoral head were similar in GI and GII, the lumbar vertebral T score was significantly lower in GI than in GII (P < .052). Conclusion. AVN developed within the first year after transplantation. Decreased lumbar vertebral BMD, which can be an indicator of glucocorticoid effect, accompanied AVN in nearly all patients. Despite the absence of renal dysfunction, increased bone destruction, anemia, and leucocytosis were coincidental or accompanying findings in our patients with AVN.
引用
收藏
页码:863 / 866
页数:4
相关论文
共 50 条
  • [31] ANEMIA IN RENAL TRANSPLANT RECIPIENTS
    Nayak, Shobhana
    Kiran, M. K.
    Reddy, Vikranth
    Fernandes, Kiran
    Anil, B. T.
    Gopalkrishna, G.
    Shastry, J. C. M.
    NEPHROLOGY, 2005, 10 : A102 - A102
  • [32] FAT MASS AS AN AGGRAVATING FACTOR FOR REDUCED BONE MINERAL DENSITY (BMD) IN RENAL TRANSPLANT RECIPIENTS
    Baxmann, Alesssandra C.
    Menon, Viviane B.
    Moreira, Silvia R.
    Medina-Pestana, Jose
    Carvalho, Aluizio B.
    Heilberg, Ita P.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 387 - 388
  • [33] Determinants of Bone Mineral Density in Stable Renal Transplant Recipients: Not Always What You Expect
    Gupta, Alok K.
    Huang, Michael
    Wong, Steven C. W.
    Prasad, G. V. Ramesh
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 67 - 68
  • [34] Determinants of bone mineral density in stable kidney transplant recipients
    Gupta, Alok K.
    Huang, Michael
    Prasad, G. V. Ramesh
    JOURNAL OF NEPHROLOGY, 2012, 25 (03) : 373 - 383
  • [35] Late onset Avascular Osteonecrosis: A debilitating complication with high prevalence among young renal transplant recipients
    Devetzis, Vasileios
    Maurer, Anita
    Uyen Huynh-Do
    Arampatzis, Spyridon
    SWISS MEDICAL WEEKLY, 2015, 145 : 42S - 42S
  • [36] Racial differences in bone mineral density in liver transplant recipients
    Yasin, IS
    Kukreja, C
    Testa, G
    Benedetti, E
    Cotler, S
    GASTROENTEROLOGY, 2005, 128 (04) : A757 - A757
  • [37] Bone mineral disorders in pediatric and adolescent renal transplant recipients
    Derakhshan, Ali
    Behbahan, Afshin G.
    Lotfi, Mehrzad
    Omrani, Gholam-Hossein
    Fallahzadeh, Mohammad-Hossein
    Basiratnia, Mitra
    Al-Hashemi, Ghamar H.
    PEDIATRIC TRANSPLANTATION, 2011, 15 (04) : 367 - 375
  • [38] BONE-MINERAL DENSITY IN KIDNEY-TRANSPLANT RECIPIENTS
    DEVOGELAER, JP
    GERARDO, J
    PIRSON, Y
    DESTRIHOU, CV
    DEDEUXCHAISNES, N
    JOURNAL OF BONE AND MINERAL RESEARCH, 1992, 7 : S290 - S290
  • [39] Plasma n-3 Polyunsaturated Fatty Acids and Bone Mineral Density in Renal Transplant Recipients
    Jorgensen, Hanne Skou
    Eide, Ivar Anders
    Hartmann, Anders
    Asberg, Anders
    Christensen, Jeppe Hagstrup
    Schmidt, Erik Berg
    Godang, Kristin
    Bollerslev, Jens
    Svensson, My
    JOURNAL OF RENAL NUTRITION, 2016, 26 (03) : 196 - 203
  • [40] REMODELING ACTIVTY IS THE MAIN DRIVER OF BONE MINERAL DENSITY CHANGES IN DE NOVO RENAL TRANSPLANT RECIPIENTS
    Evenepoel, Pieter
    Claes, Kathleen
    Meijers, Bjorn
    Laurent, Michael
    Bammens, Bert
    Naesens, Maarten
    Sprangers, Ben
    Cavalier, Etienne
    Kuypers, Dirk
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33